The DOI matches its Crossref record.
Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells
Abstract
We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-I-carrier with Sjögren syndrome, and an asymptomatic HTLV-I-carrier, by repeated stimulation with autologous HTLV-I-infected T cells in vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-I-specific cytotoxicity was also inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly induced from the asymptomatic HTLV-I-carrier, which were highly cytotoxic to autologous HTLV-I-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells
Satou, Y., Yasunaga, J.-I., Yoshida, M., & Matsuoka, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507631103 · Cited by 593
Jeffery, K. J. M., Usuku, K., Hall, S. E., Matsumoto, W., Taylor, G. P., Procter, J., Bunce, M., Ogg, G. S., Welsh, K. I., Weber, J. N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3848 · Cited by 419
Self-citationHUMAN T CELL LEUKEMIA VIRUS TYPE I (HTLV-I) AND HUMAN DISEASES
Uchiyama, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.15 · Cited by 392
Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection
Franchini, G. (1995) · Blood · doi:10.1182/blood.v86.10.3619.bloodjournal86103619 · Cited by 360
Genetic and epigenetic inactivation of tax gene in adult T‐cell leukemia cells
Takeda, S., Maeda, M., Morikawa, S., Taniguchi, Y., Yasunaga, J., Nosaka, K., Tanaka, Y., & Matsuoka, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20007 · Cited by 348
HTLV-1-associated myelopathy/tropical spastic paraparesis
Bangham, C. R. M., Araujo, A., Yamano, Y., & Taylor, G. P. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.12 · Cited by 279
Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia
Tamiya, S., Matsuoka, M., Etoh, K., Watanabe, T., Kamihira, S., Yamaguchi, K., & Takatsuki, K. (1996) · Blood · doi:10.1182/blood.v88.8.3065.bloodjournal8883065 · Cited by 263
The immune control and cell-to-cell spread of human T-lymphotropic virus type 1
Bangham, C. R. M. (2003) · Journal of General Virology · doi:10.1099/vir.0.19334-0 · Cited by 260
Jeffery, K. J. M., Siddiqui, A. A., Bunce, M., Lloyd, A. L., Vine, A. M., Witkover, A. D., Izumo, S., Usuku, K., Welsh, K. I., Osame, M., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7278 · Cited by 222
Self-citationTherapeutic trials in 200 patients with HTLV-Iassociated myelopathy/tropical spastic paraparesis
Nakagawa, M., Nakahara, K., Maruyama, Y., Kawabata, M., Higuchi, I., Kubota, H., Izumo, S., Arimura, K., & Osame, M. (1996) · Journal of Neurovirology · doi:10.3109/13550289609146899 · Cited by 150
Self-citationAPOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo
Fan, J., Ma, G., Nosaka, K., Tanabe, J., Satou, Y., Koito, A., Wain-Hobson, S., Vartanian, J.-P., & Matsuoka, M. (2010) · Journal of Virology · doi:10.1128/jvi.02239-09 · Cited by 130
Cowan, E. P., Alexander, R. K., Daniel, S., Kashanchi, F., & Brady, J. N. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6982-6989.1997 · Cited by 63
Miyazato, P., Yasunaga, J.-I., Taniguchi, Y., Koyanagi, Y., Mitsuya, H., & Matsuoka, M. (2006) · Journal of Virology · doi:10.1128/jvi.01009-06 · Cited by 54
“On the other hand, Tax-expressing cells are rapidly eliminated in vivo, since the Tax protein is a major target antigen of cytotoxic T lymphocytes (CTLs) (4, 27 ).”
BackgroundPotential immunogenicity of adult T cell leukemia cells in vivo
Kurihara, K., Harashima, N., Hanabuchi, S., Masuda, M., Utsunomiya, A., Tanosaki, R., Tomonaga, M., Ohashi, T., Hasegawa, A., Masuda, T., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20737 · Cited by 47
Self-citationMaeda, M., Tanabe-Shibuya, J., Miyazato, P., Masutani, H., Yasunaga, J.-I., Usami, K., Shimizu, A., & Matsuoka, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00356 · Cited by 22
Current State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22
“Treatments for HTLV-1-associated diseases and infection.”
In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions
Izaki, M., Yasunaga, J.-I., Nosaka, K., Sugata, K., Utsunomiya, H., Suehiro, Y., Shichijo, T., Yamada, A., Sugawara, Y., Hibi, T., et al. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009271 · Cited by 15
“Dynamics of HTLV-1-infected clones in patients who received Tax peptide pulsed dendritic cell vaccine Tax is the immunodominant target of CTLs in vivo [9].”
BackgroundInfluential
Metadata
- Authors
- Kannagi, M., Harada, S., Maruyama, I., Inoko, H., Igarashi, H., Kuwashima, G., Sato, S., Morita, M., Kidokoro, M., Sugimoto, M., Funahashi, S.-I., Osame, M., Shida, H., & Honjo, T.
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1991
- Volume
- 3
- Issue
- 8
- Pages
- 761-767
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2158178382
- Cited by
- 253
- References
- 0
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.